
Enzo Biochem Investor Relations Material
Latest events

Q1 2023
Enzo Biochem

Q2 2025
17 Mar, 2025

Q1 2025
15 Dec, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Enzo Biochem Inc
Access all reports
Enzo Biochem, Inc., an integrated diagnostics, clinical lab, and life sciences company, researches, develops, manufactures, and markets diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. Our products include DNA probes and primers; cell imaging systems; hematology-based products that automate the identification of abnormal cells in blood; and research kits. The company also provides clinical lab services to physicians, medical centers, and other clinicians. The company serves clients worldwide.
Latest articles
)
MSCI: Indexing the World
The story of how MSCI has become the backbone of global finance through its indexes, powering decision-making across trillions in assets.
30 May 2025
)
A Purpose-Built AI Chat for Finance and IR Professionals
Quartr Pro's new AI chat lets IR and finance professionals ask anything across 13,000+ public companies and get instant answers.
27 May 2025
)
Costco Wholesale: The Model of Scalable Simplicity
Costco's rise from warehouse club to retail giant is built on low prices, scale efficiency, and a model designed for lasting customer value.
26 May 2025
Ticker symbol
ENZ
Country
🇺🇸 United States